ask="43.87"
ask_size="1100"
average_daily_volume="1132990"
bid="41.20"
bid_size="100"
book_value="4.05"
change="-0.07"
change_from_200_day_moving_average="-3.33"
change_from_50_day_moving_average="2.37"
change_from_52_week_high="-11.91"
change_From_52_week_low="11.99"
change_in_percent="-0.16%"
close="43.24"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85781000"
high="43.63"
high_52_weeks="55.15"
last_trade_date="2/6/2017"
last_trade_price="43.24"
last_trade_size="18170"
last_trade_time="4:00pm"
low="42.59"
low_52_weeks="31.25"
market_capitalization="3.76B"
moving_average_200_day="46.57"
moving_average_50_day="40.87"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="43.25"
pe_ratio="N/A"
peg_ratio="0.73"
percent_change_from_200_day_moving_average="-7.15%"
percent_change_from_50_day_moving_average="+5.81%"
percent_change_from_52_week_high="-21.60%"
percent_change_from_52_week_low="+38.37%"
previous_close="43.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.70"
price_per_sales="250.83"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="725024"
weeks_range_52="31.25 - 55.15"
